Izraēla - ivrits - Ministry of Health

teva pharmaceutical industries ltd, israel - clopidogrel as bisulfate - טבליה - clopidogrel as bisulfate 75 mg - clopidogrel - clopidogrel - clopidogrel is indicated for the prevention of atherothrombotic events as follows : * recent mi recent stroke or established peripheral arterial disease : - patients suffering from myocardial infarction (from a few days until less than 35 days ) - ischaemic stroke ( from 7 days until less than 6 months) or established peripheral arterial disease. - for patients with a history of recent myocardial infarction (mi) recent stroke or established peripheral arterial disease - clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not) new mi (fatal or not) and other vascular death. * acute coronary syndrome: - for patients with acute coronary syndrome [non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave mi) or st segment elevation acute myocardial infarction ] in combination with asa in medically treated patients eligible for thrombolytic therapy and those who are to be managed with percutaneous coronary intervention (with or without stent) or

Izraēla - ivrits - Ministry of Health

merck sharp & dohme israel ltd - protein l1 (type 11); protein l1 (type 16); protein l1 (type 18); protein l1 (type 6) - תרחיף להזרקה - protein l1 (type 18) 20 mcg / 0.5 ml; protein l1 (type 6) 20 mcg / 0.5 ml; protein l1 (type 11) 40 mcg / 0.5 ml; protein l1 (type 16) 40 mcg / 0.5 ml - combinations - combinations - gardasil is indicated in females aged 9 through 45 years* for the prevention of cervical, vulvar, vaginal cancer, precancerous or dysplastic lesions, genital warts, and infection caused by human papillomavirus (hpv) types 6, 11, 16, and 18 (which are included in the vaccine). gardasil is indicated in males 9 through 26 years* of age for the prevention of anal cancer, precancerous or dysplastic lesions, external genital lesions and infection caused by hpv types 6, 11, 16, and 18 (which are included in the vaccine). *immunogenicity studies have been conducted to link efficacy in females and males aged 16 to 26 years to the younger populations..

Izraēla - ivrits - Ministry of Health

perrigo israel pharmaceuticals ltd - isosorbide-5-mononitrate - טבליה - isosorbide-5-mononitrate 40 mg - isosorbide mononitrate - isosorbide mononitrate - prophilactic treatment of angina pectoris. treatment of congestive heart failure.

Izraēla - ivrits - Ministry of Health

glaxo smith kline (israel) ltd - ambrisentan - טבליות מצופות פילם - ambrisentan 5 mg - ambrisentan - volibris is indicated for the treatment of patients with pulmonary arterial hypertension (pah) classified as who functional class ii and iii, to improve exercise capacity . efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease.

Izraēla - ivrits - Ministry of Health

glaxo smith kline (israel) ltd - ambrisentan - טבליות מצופות פילם - ambrisentan 10 mg - ambrisentan - volibris is indicated for the treatment of patients with pulmonary arterial hypertension (pah) classified as who functional class ii and iii, to improve exercise capacity . efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease.

Izraēla - ivrits - Ministry of Health

dexcel ltd, israel - enalapril maleate; lercanidipine hydrochloride - טבליה - lercanidipine hydrochloride 10 mg; enalapril maleate 20 mg - enalapril - enalapril - treatment of essential hypertension in patients whose blood pressure cannot be adequately controlled under enalapril monotherapy.

Izraēla - ivrits - Ministry of Health

dexcel ltd, israel - enalapril maleate; lercanidipine hydrochloride - טבליה - lercanidipine hydrochloride 10 mg; enalapril maleate 10 mg - enalapril - enalapril - treatment of essential hypertension in whose blood pressure cannot be adequately controlled under lercanidipine monotherapy.

Izraēla - ivrits - Ministry of Health

cts chemical industries ltd, israel - losartan potassium - טבליה - losartan potassium 12.5 mg - losartan - losartan - hypertension : losartan is indicated for the treatment of hypertension. heart failure: losartan is indicated for the treatment of heart failure (nyha ii) when treatment with an ace inhibitor is no longer considered appropriate. switching patients with heart failure who are stable on an ace inhibitor to losartan is not recommended.

Izraēla - ivrits - Ministry of Health

cts chemical industries ltd, israel - hydrochlorothiazide; losartan potassium - טבליה - hydrochlorothiazide 12.5 mg; losartan potassium 50 mg - losartan and diuretics - losartan and diuretics - for the treatment of hypertension, for patients in whom combination therapy is appropriate. to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy.

Izraēla - ivrits - Ministry of Health

glaxo smith kline (israel) ltd - aciclovir - טבליה - aciclovir 400 mg - aciclovir - aciclovir - for the treatment of herpes simplex virus infections of the skin and mucous membranes including intial and recurrent genital herpes. for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. for the prophylaxis of herpes simplex infections in immune-compromised patients. for the treatment of herpes zoster infections . for the treatment of chickenpox.